title: Measuring reversal of HIV-1 latency ex vivo using cells from infected individuals.
authors.affiliation: Department of Medicine and.
authors.forename: Ya-Chi
authors.initials: YC
authors.lastname: Ho
authors.affiliation: Department of Medicine and.
authors.forename: Gregory M
authors.initials: GM
authors.lastname: Laird
authors.affiliation: Department of Medicine andHoward Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205 rsiliciano@jhmi.edu.
authors.forename: Robert F
authors.initials: RF
authors.lastname: Siliciano
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000821:virology*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000254:growth & development*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008297:Male; D017735:Virus Latency / Q000187:drug effects*; D000077337:Vorinostat
chemical_list: D044966:Anti-Retroviral Agents; D006877:Hydroxamic Acids; D000077337:Vorinostat